Oxford Asset Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-109,575
Closed -$8.52M – 578
2019
Q4
$8.52M Buy
109,575
+92,904
+557% +$7.25M 0.24% 92
2019
Q3
$1.22M Buy
+16,671
New +$1.17M 0.03% 827
2019
Q2
– Sell
-13,695
Closed -$873K – 1782
2019
Q1
$873K Buy
+13,695
New +$782K 0.02% 992
2018
Q3
– Sell
-10,575
Closed -$514K – 1749
2018
Q2
$514K Sell
10,575
-73,122
-87% -$3.41M 0.01% 1333
2018
Q1
$3.89M Sell
83,697
-25,485
-23% -$1.11M 0.08% 259
2017
Q4
$4.17M Buy
+109,182
New +$4.01M 0.09% 273
2017
Q3
– Sell
-17,952
Closed -$708K – 1577
2017
Q2
$708K Buy
+17,952
New +$655K 0.01% 1007
2016
Q4
– Sell
-58,500
Closed -$2.35M – 801
2016
Q3
$2.35M Buy
+58,500
New +$2.2M 0.07% 371
2015
Q3
– Sell
-410,430
Closed -$9.74M – 651
2015
Q2
$9.74M Sell
410,430
-231,060
-36% -$5.21M 0.26% 77
2015
Q1
$15.2M Buy
641,490
+41,748
+7% +$937K 0.39% 39
2014
Q4
$13M Sell
599,742
-88,500
-13% -$1.78M 0.29% 56
2014
Q3
$11.7M Buy
+688,242
New +$10.9M 0.27% 72
2014
Q2
– Sell
-166,566
Closed -$2.06M – 719
2014
Q1
$2.06M Buy
+166,566
New +$1.92M 0.06% 356

Other funds holding EW

Oxford Asset Management's EW Position: Q1 2020 in Review

Oxford Asset Management sold out of Edwards Lifesciences (EW) in Q1 2020, closing a stake of 109,575 shares — an estimated $8.52M sold.

Oxford Asset Management first reported a position in EW in Q1 2014 and held it in 13 quarters. The position peaked at $15.2M in Q1 2015. 1,019 funds tracked by Wall St. Rank hold EW as of Q1 2020.

  • Oxford Asset Management reported no remaining Edwards Lifesciences position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 109,575 Edwards Lifesciences shares in Q1 2020, an estimated $8.52M.
  • Oxford Asset Management first reported a position in Edwards Lifesciences in Q1 2014 and held it in 13 quarters.
  • Oxford Asset Management's Edwards Lifesciences position peaked at $15.2M in Q1 2015.
  • 1,019 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.